241 related articles for article (PubMed ID: 33028413)
1. Extracellular volume fraction measurement correlates with lymphocyte abundance in thymic epithelial tumors.
Chang CC; Lin CY; Chu CY; Hsiung YC; Chuang MT; Tseng YL; Yen YT
Cancer Imaging; 2020 Oct; 20(1):71. PubMed ID: 33028413
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of iodine concentration and extracellular volume fraction measurement derived from the equilibrium phase dual-energy CT for differentiating thymic epithelial tumors.
Takumi K; Nagano H; Myogasako T; Nakano T; Fukukura Y; Ueda K; Tabata K; Tanimoto A; Yoshiura T
Jpn J Radiol; 2023 Jan; 41(1):45-53. PubMed ID: 36029365
[TBL] [Abstract][Full Text] [Related]
3. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis?
Jeong YJ; Lee KS; Kim J; Shim YM; Han J; Kwon OJ
AJR Am J Roentgenol; 2004 Aug; 183(2):283-9. PubMed ID: 15269013
[TBL] [Abstract][Full Text] [Related]
4. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
Fukumoto K; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Kato K; Matsuo K; Yokoi K
Eur J Cardiothorac Surg; 2012 Dec; 42(6):e152-6. PubMed ID: 23024234
[TBL] [Abstract][Full Text] [Related]
5. Dual-energy CT perfusion imaging for differentiating WHO subtypes of thymic epithelial tumors.
Yu C; Li T; Zhang R; Yang X; Yang Z; Xin L; Zhao Z
Sci Rep; 2020 Mar; 10(1):5511. PubMed ID: 32218504
[TBL] [Abstract][Full Text] [Related]
6. Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis.
Treglia G; Sadeghi R; Giovanella L; Cafarotti S; Filosso P; Lococo F
Lung Cancer; 2014 Oct; 86(1):5-13. PubMed ID: 25175317
[TBL] [Abstract][Full Text] [Related]
7. Using the World Health Organization Classification of thymic epithelial neoplasms to describe CT findings.
Tomiyama N; Johkoh T; Mihara N; Honda O; Kozuka T; Koyama M; Hamada S; Okumura M; Ohta M; Eimoto T; Miyagawa M; Müller NL; Ikezoe J; Nakamura H
AJR Am J Roentgenol; 2002 Oct; 179(4):881-6. PubMed ID: 12239030
[TBL] [Abstract][Full Text] [Related]
8. Doubling time of thymic epithelial tumours on CT: correlation with histological subtype.
Choe J; Lee SM; Lim S; Choi SH; Kim N; Do KH; Seo JB
Eur Radiol; 2017 Oct; 27(10):4030-4036. PubMed ID: 28332015
[TBL] [Abstract][Full Text] [Related]
9. Quantitative CT parameters combined with preoperative systemic inflammatory markers for differentiating risk subgroups of thymic epithelial tumors.
Gao R; Zhou J; Zhang J; Zhu J; Wang T; Yan C
BMC Cancer; 2023 Nov; 23(1):1158. PubMed ID: 38012604
[TBL] [Abstract][Full Text] [Related]
10. Histogram analysis of apparent diffusion coefficient maps for assessing thymic epithelial tumours: correlation with world health organization classification and clinical staging.
Kong LY; Zhang W; Zhou Y; Xu H; Shi HB; Feng Q; Xu XQ; Yu TF
Br J Radiol; 2018 Apr; 91(1084):20170580. PubMed ID: 29260882
[TBL] [Abstract][Full Text] [Related]
11. The tumor doubling time is a useful parameter for predicting the histological type of thymic epithelial tumors.
Fukumoto K; Fukui T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Mori S; Goto M; Hashimoto K; Tateyama H; Yokoi K
Surg Today; 2019 Aug; 49(8):656-660. PubMed ID: 31134370
[TBL] [Abstract][Full Text] [Related]
12. JOURNAL CLUB: Doubling Time of Thymic Epithelial Tumors Correlates With World Health Organization Histopathologic Classification.
Jeong DY; Lee KS; Chung MJ; Zo JI; Shim YM; Moon JW
AJR Am J Roentgenol; 2017 Oct; 209(4):W202-W210. PubMed ID: 28796544
[TBL] [Abstract][Full Text] [Related]
13. Volume-based quantification using dual-energy computed tomography in the differentiation of thymic epithelial tumours: an initial experience.
Chang S; Hur J; Im DJ; Suh YJ; Hong YJ; Lee HJ; Kim YJ; Han K; Kim DJ; Lee CY; Shin HY; Choi BW
Eur Radiol; 2017 May; 27(5):1992-2001. PubMed ID: 27553938
[TBL] [Abstract][Full Text] [Related]
14. Prediction of thymoma histology and stage by radiographic criteria.
Yanagawa M; Tomiyama N
Thorac Surg Clin; 2011 Feb; 21(1):1-12, v. PubMed ID: 21070982
[TBL] [Abstract][Full Text] [Related]
15. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival.
Seki N; Sakamoto S; Karube Y; Oyaizu T; Ishihama H; Chida M
Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867
[TBL] [Abstract][Full Text] [Related]
16. Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT.
Lee HS; Oh JS; Park YS; Jang SJ; Choi IS; Ryu JS
Ann Nucl Med; 2016 May; 30(4):309-19. PubMed ID: 26868139
[TBL] [Abstract][Full Text] [Related]
17. Radiologic Response to Neoadjuvant Treatment Predicts Histologic Response in Thymic Epithelial Tumors.
Johnson GB; Aubry MC; Yi ES; Koo CW; Jenkins SM; Garces YI; Marks RS; Cassivi SD; Roden AC
J Thorac Oncol; 2017 Feb; 12(2):354-367. PubMed ID: 27666658
[TBL] [Abstract][Full Text] [Related]
18. Extracellular volume fraction derived from equilibrium contrast-enhanced CT as a diagnostic parameter in anterior mediastinal tumors.
Takumi K; Nagano H; Oose A; Gohara M; Kamimura K; Nakajo M; Harada-Takeda A; Ueda K; Tabata K; Yoshiura T
Eur J Radiol; 2023 Aug; 165():110891. PubMed ID: 37245341
[TBL] [Abstract][Full Text] [Related]
19. Value of 18F-FDG PET/CT for Predicting the World Health Organization Malignant Grade of Thymic Epithelial Tumors: Focused in Volume-Dependent Parameters.
Park SY; Cho A; Bae MK; Lee CY; Kim DJ; Chung KY
Clin Nucl Med; 2016 Jan; 41(1):15-20. PubMed ID: 26545017
[TBL] [Abstract][Full Text] [Related]
20. The maximal contrast-enhanced range of CT for differentiating the WHO pathological subtypes and risk subgroups of thymic epithelial tumors.
Yu C; Li T; Yang X; Xin L; Zhao Z; Yang Z; Zhang R
Br J Radiol; 2023 Oct; 96(1150):20221076. PubMed ID: 37486626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
